Exosens
EXENS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €2 | €1 | €1 | €1 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €2 | €1 | €1 | €1 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 8.3% | 10.9% | 12% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 62% | 22.7% | 95.5% | 82.5% |
| EBITDA | €0 | €0 | €0 | €0 |
| % Margin | 25.6% | 21.9% | 21.6% | 37.2% |
| Net Income | €0 | €0 | -€0 | €0 |
| % Margin | 12.4% | 13.4% | -0.3% | 5% |
| EPS Diluted | 0.55 | 0.65 | -0.045 | 0.085 |
| % Growth | -15.4% | 1,544.4% | -153.1% | – |
| Operating Cash Flow | €0 | €0 | €0 | €0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | €0 | €0 | €0 | €0 |